Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
about
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and ApplicationPreparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oilLiposomes in cosmeceutics.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery.Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonide.Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect.Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles.The effect of surfactant composition on the chemical and structural properties of nanostructured lipid carriers
P2860
Q26778603-CFCE0E6A-0967-4956-9591-3C4741E81716Q35972656-75107707-6D4D-4194-AB98-BF1A22862A7FQ37993122-D7784E23-4906-4523-8339-363EFF25B90BQ38042744-E63C4345-F5DE-4BD3-B014-7B7BEE481BB4Q38095485-C60C42C8-F543-4D1C-AE86-3D50D1C787EBQ38199540-23748799-0048-46D0-A1F1-23347E527C16Q38648168-0D34AB37-EFB8-43C7-B3C7-C6A447C41835Q38714705-796A961A-E8ED-42F5-B5B5-6559EEB1D1B6Q38723241-FA4BDDD2-90FB-49B9-8C6D-88E055347E6DQ39024424-4F1FD275-04AB-4859-8DBF-1611BFD9E857Q39518383-D098C3C1-D8AB-41C3-8332-18A8BBF1B0C1Q41195499-D8430F1E-67C1-4BE8-BD0F-2D06029FB334Q42207993-BF941B0A-AC8F-48AD-9A3E-486FA9399A75Q47447720-2CAE3F19-D312-4FDC-BF35-17DA9F190A56Q48132393-57F97EC8-F4A1-4388-87BA-1C2302CA6342Q48135670-65F3E2EC-AC19-4F81-91EA-2A5B4761B8C7Q57165159-A866C551-1FEE-4340-A714-85E50FBE4FE5
P2860
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
@en
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
@nl
type
label
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
@en
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
@nl
prefLabel
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
@en
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
@nl
P1476
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes
@en
P2093
Rainer H Müller
P304
P356
10.1007/978-3-642-00477-3_4
P577
2010-01-01T00:00:00Z